open access

Vol 52, No 5 (2018)
Original research articles
Submitted: 2018-06-16
Get Citation

Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report

Savas Sencan, Ozge Kenis-Coskun, Fatma Gul Ulku Demir, Isa Cuce, Tulay Ercalık, Osman Hakan Gunduz
DOI: 10.1016/j.pjnns.2018.08.006
·
Neurol Neurochir Pol 2018;52(5):612-617.

open access

Vol 52, No 5 (2018)
Original research articles
Submitted: 2018-06-16

Abstract

Aim of the study

To define the effectiveness of ganglion Impar block in improving neuropathic pain.

Materials and methods

Patients who had pain around the coccyx for more than three months and did not respond to conservative treatment were included in this study. All the patients underwent fluoroscopy guided transsacrococcygeal ganglion Impar block with injecting 3 mL of 0.5% bupivacaine, 2 mL saline, and 1 mL (40 mg) of methylprednisolone. Patients were evaluated with visual analog scale (VAS) for pain, Leeds assessment of neuropathic symptoms and signs scale (LANSS) for neuropathic pain, Beck depression Inventory (BDI) for mood and Short-form 12 (SF-12) for quality of life before, 1 month 3 months and 6 months after the injection. Patients’ painless sitting duration was also recorded.

Results

A total of 28 patients were included in the final analyses. VAS and LANSS scores improved significantly throughout the follow-up periods. BDI scores also improved while SF-12 scores did not show significant changes. Painless sitting period of the patients’ improved significantly.

Conclusions

Ganglion Impar block is effective in decreasing the neuropathic component of chronic coccygodynia. This improves painless sitting in patients but its reflections on quality of life is not clear.

Abstract

Aim of the study

To define the effectiveness of ganglion Impar block in improving neuropathic pain.

Materials and methods

Patients who had pain around the coccyx for more than three months and did not respond to conservative treatment were included in this study. All the patients underwent fluoroscopy guided transsacrococcygeal ganglion Impar block with injecting 3 mL of 0.5% bupivacaine, 2 mL saline, and 1 mL (40 mg) of methylprednisolone. Patients were evaluated with visual analog scale (VAS) for pain, Leeds assessment of neuropathic symptoms and signs scale (LANSS) for neuropathic pain, Beck depression Inventory (BDI) for mood and Short-form 12 (SF-12) for quality of life before, 1 month 3 months and 6 months after the injection. Patients’ painless sitting duration was also recorded.

Results

A total of 28 patients were included in the final analyses. VAS and LANSS scores improved significantly throughout the follow-up periods. BDI scores also improved while SF-12 scores did not show significant changes. Painless sitting period of the patients’ improved significantly.

Conclusions

Ganglion Impar block is effective in decreasing the neuropathic component of chronic coccygodynia. This improves painless sitting in patients but its reflections on quality of life is not clear.

Get Citation

Keywords

Coccygodynia, Ganglion Impar, Neuropathic pain, Sympathetic block

About this article
Title

Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 52, No 5 (2018)

Pages

612-617

DOI

10.1016/j.pjnns.2018.08.006

Bibliographic record

Neurol Neurochir Pol 2018;52(5):612-617.

Keywords

Coccygodynia
Ganglion Impar
Neuropathic pain
Sympathetic block

Authors

Savas Sencan
Ozge Kenis-Coskun
Fatma Gul Ulku Demir
Isa Cuce
Tulay Ercalık
Osman Hakan Gunduz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl